Aseptic Meningitis after BNT-162b2 COVID-19 Vaccination: Case Report and Literature Review

Keio J Med. 2023 Sep 23. doi: 10.2302/kjm.2022-0034-CR. Online ahead of print.ABSTRACTWe encountered a-27-year-old female patient who developed refractory severe headache and photophobia after the first dose of COVID-19 vaccine. Despite her prior history of migraine, we diagnosed COVID-19 vaccine-induced aseptic meningitis. Symptoms were significantly resolved after methylprednisolone therapy. On reviewing the literature, we could find only nine similar cases, with over half of them affecting women aged 20-40 years. Although uncommon, aseptic meningitis should be suspected in patients with persistent or delayed onset of headache following COVID-19 vaccination.PMID:37743529 | DOI:10.2302/kjm.2022-0034-CR
Source: The Keio Journal of Medicine - Category: Universities & Medical Training Authors: Source Type: research